Average Insider

Where insiders trade, we follow

Apogee Therapeutics, Inc. ($APGE)
Accession: 0001104659-26-105119
Sep 3, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$35.39
Current$135.07100.0% above low, 0.0% below high
52W High$135.09

Filing Information

Accession Number0001104659-26-105119
Form Type4
Filing DateSep 3, 2026
DocumentView SEC Filing
Transactions
8
Total Shares
7,266,754
Total Value
$0.00

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Fairmount Funds Management LLC
Director
Common Stock
โ€”Sep 3, 2026Sale to Issuer340,855โ€”โ€”0IndirectBy Fairmount Healthcare Fund II LPView Details
Fairmount Funds Management LLC
Director
Common Stock
โ€”Sep 3, 2026Sale to Issuer51,166โ€”โ€”0IndirectBy Tomas KiselakView Details
Fairmount Funds Management LLC
Director
Common Stock
โ€”Sep 3, 2026Sale to Issuer51,166โ€”โ€”0IndirectBy Peter HarwinView Details
Fairmount Funds Management LLC
Director
Non-Voting Common Stock
(Common Stock)
DerivativeSep 3, 2026Sale to Issuer6,743,321โ€”โ€”0IndirectBy Fairmount Healthcare Fund II LPView Details
Fairmount Funds Management LLC
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeSep 3, 2026Sale to Issuer47,758โ€”โ€”0IndirectBy Tomas KiselakView Details
Fairmount Funds Management LLC
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeSep 3, 2026Sale to Issuer10,370โ€”โ€”0IndirectBy Tomas KiselakView Details
Fairmount Funds Management LLC
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeSep 3, 2026Sale to Issuer14,461โ€”โ€”0IndirectBy Tomas KiselakView Details
Fairmount Funds Management LLC
Director
Stock Option (Right to Buy)
(Common Stock)
DerivativeSep 3, 2026Sale to Issuer7,657โ€”โ€”0IndirectBy Tomas KiselakView Details
Version: v26.9.2